Header cover image

South Korean (KOSPI) Life Sciences Industry Analysis

UpdatedNov 19, 2025
DataAggregated Company Financials
Companies27
  • 7D1.1%
  • 3M19.5%
  • 1Y39.0%
  • YTD38.9%

Over the last 7 days, the Life Sciences industry has risen 1.1%, driven by gains from Peptron of 14%. Meanwhile, ENCell actually underperformed within the industry, shrinking 8.5% in the last week. In the last 12 months, the industry was up 39%. Earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the South Korean Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 20 Nov 2025₩104.1t₩5.8t₩1.2t16.7x87.2x17.8x
Sat, 18 Oct 2025₩93.1t₩5.8t₩1.2t16x78.5x15.9x
Mon, 15 Sep 2025₩89.4t₩5.8t₩1.2t14.6x75.4x15.3x
Wed, 13 Aug 2025₩87.8t₩5.7t₩1.2t16.6x71.6x15.5x
Fri, 11 Jul 2025₩89.2t₩5.6t₩1.2t15.6x72.4x15.9x
Sun, 08 Jun 2025₩82.4t₩5.6t₩1.2t15.4x66.8x14.7x
Tue, 06 May 2025₩87.4t₩5.2t₩1.0t18.2x85.3x16.7x
Thu, 03 Apr 2025₩83.0t₩5.2t₩1.0t17.3x80.7x15.9x
Sat, 01 Mar 2025₩87.9t₩5.2t₩996.4b12.6x88.2x16.9x
Mon, 27 Jan 2025₩86.6t₩5.0t₩965.6b12.9x89.6x17.3x
Wed, 25 Dec 2024₩74.7t₩5.0t₩965.6b13.1x77.4x14.9x
Fri, 22 Nov 2024₩74.2t₩4.8t₩885.3b13.8x83.8x15.3x
Sun, 20 Oct 2024₩84.8t₩4.8t₩885.3b14.3x95.8x17.5x
Tue, 17 Sep 2024₩77.4t₩4.8t₩885.3b14x87.5x16x
Thu, 15 Aug 2024₩73.3t₩4.5t₩731.7b15.6x100.2x16.2x
Sat, 13 Jul 2024₩65.4t₩4.5t₩731.7b18.4x89.4x14.4x
Mon, 10 Jun 2024₩59.4t₩4.6t₩689.6b19.2x86.1x12.9x
Wed, 08 May 2024₩61.7t₩4.4t₩635.1b20x97.2x14.1x
Fri, 05 Apr 2024₩64.6t₩4.7t₩656.9b19x98.4x13.8x
Sun, 03 Mar 2024₩60.7t₩4.6t₩635.2b34.6x95.6x13.1x
Tue, 30 Jan 2024₩62.6t₩4.5t₩714.4b34.3x87.7x13.8x
Thu, 28 Dec 2023₩58.2t₩4.5t₩721.5b32.6x80.7x12.8x
Sat, 25 Nov 2023₩56.1t₩4.6t₩742.0b21.9x75.6x12.3x
Mon, 23 Oct 2023₩55.3t₩4.4t₩660.9b27.1x83.7x12.6x
Wed, 20 Sep 2023₩58.2t₩4.4t₩660.9b30.7x88.1x13.2x
Fri, 18 Aug 2023₩60.7t₩4.2t₩673.4b28.2x90.2x14.5x
Sun, 16 Jul 2023₩58.0t₩4.2t₩673.4b29.1x86.2x13.8x
Tue, 13 Jun 2023₩61.8t₩4.2t₩666.5b30.4x92.7x14.5x
Thu, 11 May 2023₩61.1t₩4.1t₩626.3b27.6x97.5x14.9x
Sat, 08 Apr 2023₩62.3t₩4.1t₩626.3b28.9x99.4x15.2x
Mon, 06 Mar 2023₩61.6t₩3.5t₩427.8b21.5x144.1x17.7x
Wed, 01 Feb 2023₩62.0t₩3.5t₩426.6b20.1x145.4x17.8x
Fri, 30 Dec 2022₩64.1t₩3.4t₩428.7b21.3x149.6x18.7x
Sun, 27 Nov 2022₩69.8t₩3.4t₩441.6b21.9x158x20.5x
Price to Earnings Ratio

158x


Total Market Cap: ₩69.8tTotal Earnings: ₩441.6bTotal Revenue: ₩3.4tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Life Sciences Industry Price to Earnings3Y Average 92.3x202320242025
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 87.2x which is lower than its 3-year average PE of 92.3x.
  • The 3-year average PS ratio of 15.2x is lower than the industry's current PS ratio of 17.8x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 39% per year over the last three years.
  • Revenues for these companies have grown 20% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market-5.12%
Healthcare0.40%
Life Sciences1.11%
Clinical Research and Equipment1.11%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A087010 Peptron₩334.50k13.8%
+₩944.4b
222.6%PS1506.1x
A220100 FutureChemLtd₩30.60k25.7%
+₩138.1b
90.8%PS35.3x
A141080 LigaChem Biosciences₩173.40k1.6%
+₩98.3b
70.7%PE3604.5x
A445680 Curiox Biosystems₩72.80k0.8%
+₩10.3b
269.9%PS325.2x
A296160 Progen₩7.45k7.3%
+₩7.3b
10.7%n/a

Latest News